Patent Assignment
Reel/Frame 024953/0525
Security Agreement
Recorded: 2010-09-08
Pages: 12
Assignor
INTARCIA THERAPEUTICS, INC.
Executed: 2010-08-31
Assignees
OXFORD FINANCE CORPORATION
133 NORTH FAIRFAX STREET, ALEXANDRIA, VIRGINIA, 22314
SILICON VALLEY BANK
555 MISSION STREET, SUITE 900, SAN FRANCISCO, CALIFORNIA, 94105
Covered Properties
(60)
Sustained Delivery of Leuprolide Using an Implantable System
Patent:
5,728,396 →
Application:
08/791,699 →
Sustained Delivery of an Active Agent Using an Implantable System
Patent:
5,985,305 →
Application:
08/943,007 →
Osmotic Delivery System and Method for Enhancing Start-Up & Performance of Osmotic Delivery Systems
Patent:
6,132,420 →
Application:
08/970,530 →
Self Adjustable Exit Port
Patent:
5,997,527 →
Application:
09/045,944 →
Beneficial Agent Delivery System with Membrane Plug and Method for Controlling Delivery of Beneficial Agents
Patent:
6,113,938 →
Application:
09/121,835 →
Osmotic Delivery System Semipermeable Body Assembly
Patent:
6,287,295 →
Application:
09/121,878 →
Osmotic Delivery System Flow Modulator Apparatus and Method
Patent:
6,524,305 →
Application:
09/122,073 →
Rate Controlling Membranes for Controlled Drug Delivery Devices
Patent:
6,375,978 →
Application:
09/213,213 →
Osmotic Delivery System with Membrane Plug Retention Mechanism
Patent:
6,270,787 →
Application:
09/217,823 →
Implanter Device for Subcutaneous Implants
Patent:
6,190,350 →
Application:
09/217,824 →
Peptide/Protein Suspending Formulations
Patent:
5,972,370 →
Application:
09/238,159 →
Trocar for Inserting Implants
Patent:
7,063,681 →
Application:
09/296,582 →
Sustained Delivery of an Active Agent Using an Implantable System
Patent:
6,156,331 →
Application:
09/310,149 →
Sustained Delivery of an Active Agent Using an Implantable System
Patent:
6,261,584 →
Application:
09/366,746 →
Self Adjustable Exit Port
Patent:
6,217,906 →
Application:
09/397,507 →
Osmotic Delivery System Having Space Efficient Piston
Patent:
6,544,252 →
Application:
09/472,600 →
Stable Non-Aqueous Single Phase Viscous Vehicles and Formulations Utilizing Such Vehicles
Patent:
7,258,869 →
Application:
09/497,422 →
Valve for Osmotic Devices
Patent:
6,508,808 →
Application:
09/748,099 →
Sustained Delivery of an Active Agent Using an Implantable System
Osmotic Delivery System with Membrane Plug Retention Mechanism
Osmotic Delivery System with Membrane Plug Retention Mechanism
Osmotic Delivery System, Osmotic Delivery System Semipermeable Body Assembly, and Method for Controlling Delivery Rate of Beneficial Agents from Osmotic Delivery Systems
Method for Treating Diseases with Omega Interferon
Application:
10/004,118 →
Publication:
US 2002/0197235
Sustained Delivery of an Active Agent Using an Implantable System
Osmotic Implant with Membrane and Membrane Retention Means
Trocar for Inserting Implants
Osmotic Delivery System Flow Modulator Apparatus and Method
Osmotic Delivery Device Having a Two-Way Valve and a Dynamically Self-Adjusting Flow Channel
Valve for Osmotic Devices
Osmotic Delivery System Having Space Efficient Piston
Osmotic Delivery System with Early Zero Order Push Power Engine
Minimally Compliant, Volume-Efficient Piston for Osmotic Drug Delivery Systems
Sustained Delivery of an Active Agent Using an Implantable System
Osmotic Pump with Means for Dissipating Internal Pressure
Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
Application:
10/815,169 →
Publication:
US 2005/0010196
Osmotically Driven Active Agent Delivery Device Providing an Ascending Release Profile
Osmotic Delivery System Having Space Efficient Piston
Osmotic Pump with Self-Retaining, Fast-Start Membrane Plug
Method for Treating Hepatitis C Virus with Omega Interferon
Composition and Dosage Form Comprising an Interferon Particle Formulation and Suspending Vehicle
Osmotic Delivery System Flow Modulator Apparatus and Method
Minimally Compliant, Volume-Efficient Piston for Osmotic Drug Delivery Systems
Osmotic Delivery Device Having a Two-Way Valve and a Dynamically Self-Adjusting Flow Channel
Solvent/Polymer Solutions as Suspension Vehicles
Implantable Device for Continuous Delivery of Interferon
Osmotic Delivery System Having Space-Efficient Piston
Polyoxaester Suspending Vehicles for Use with Implantable Delivery Systems
Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator
Osmotic Delivery Systems and Piston Assemblies for Use Therein
Suspension Formulations Comprising Vehicle, Particle, Biomolecule, And Surfactant
Application:
12/008,553 →
Publication:
US 2008/0112994
Stable Non-Aqueous Single Phase Viscous Vehicles and Formulations Utilizing Such Vehicles
Stable Non- Aqueous Single Phase Viscous Vehicles and Formulations Utlizing Such Vehicles
Suspension Formulations of Insulinotropic Peptides and Uses Thereof
Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
Application:
12/315,194 →
Publication:
US 2009/0087408
Devices, formulations, and methods for delivery of multiple beneficial agents
Highly concentrated drug particles, formulations, suspensions and uses thereof
Application:
12/587,946 →
Publication:
US 2010/0092566
Composition and Dosage Form Comprising a Particle Formulation and Suspending Vehicle
Sustained Delivery of an Active Agent Using an Implantable System
Osmotic Delivery Systems and Piston Assemblies for Use Therein
Implanter
Patent:
402,757 →
Application:
29/081,307 →
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jan 4, 2005
From: BIOMEDICINES, INC.
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 016126/0064 →
Assignment of Assignor's Interest
Oct 26, 2007
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020035/0441 →
Assignment of Assignor's Interest
Dec 13, 2007
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020252/0143 →
Assignment of Assignor's Interest
May 1, 2008
From: ALZA CORPORATION
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 020890/0738 →
Assignment of Assignor's Interest
Apr 14, 2009
From: KLEINER, LOTHAR W.; GALE, ROBERT M.; BERGGREN, RANDALL G.; TONG, GILBERT T.
To: ALZA CORPORATION
Reel/Frame 022546/0223 →
Assignment of Assignor's Interest
Aug 12, 2011
From: DIONNE, KEITH E.; LAUTENBACH, SCOTT D.
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026746/0249 →
Release of Security Interest
Sep 23, 2011
From: OXFORD FINANCE CORPORATION; SILICON VALLEY BANK
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 026962/0062 →
Security Agreement
Nov 14, 2012
From: INTARCIA THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 029299/0678 →
Assignment of Assignor's Interest
Mar 6, 2015
From: GUMUCIO, JUAN C.; DIONNE, KEITH E.; BROWN, JAMES E.
To: ALZA CORPORATION
Reel/Frame 035107/0966 →
Assignment of Assignor's Interest
Mar 6, 2015
From: ECKENHOFF, EXECUTOR OF THE LAST WILL AND TESTAMENT OF JAMES B. ECKENHOFF, BONNIE J.; HOLLADAY, LESLIE A.; LEONARD, JOHN JOSEPH, JR.; LEUNG, IRIS K. M.
To: ALZA CORPORATION
Reel/Frame 035107/0181 →
Assignment of Assignor's Interest
Mar 6, 2015
From: PEERY, JOHN R.; DIONNE, KEITH E.; ECKENHOFF, EXECUTRIX OF THE ESTATE OF JAMES B. ECKENHOFF, DECEASED, BONNIE J.; LANDRAU, FELIX A.
To: ALZA CORPORATION
Reel/Frame 035107/0175 →
Assignment of Assignor's Interest
Mar 17, 2015
From: CHEN, GUOHUA; DIONNE, KEITH E.; LAUTENBACH, SCOTT D.; JORDAN, SCOTT
To: ALZA CORPORATION
Reel/Frame 035185/0063 →
Assignment of Assignor's Interest
Mar 17, 2015
From: AYER, RUPAL
To: ALZA CORPORATION
Reel/Frame 035185/0007 →
Assignment of Assignor's Interest
Mar 17, 2015
From: PEERY, JOHN R.
To: ALZA CORPORATION
Reel/Frame 035185/0446 →
Release of Security Interest
Oct 23, 2015
From: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 036942/0544 →
Security Interest
Oct 9, 2019
From: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050673/0020 →
Security Interest
Oct 23, 2019
From: INTARCIA THERAPEUTICS, INC.
To: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C., AS COLLATERAL AGENT
Reel/Frame 050801/0267 →
Release of Security Interest
Jan 29, 2020
From: BAUPOST PRIVATE INVESTMENTS BVIV-3, L.L.C. AS COLLATERAL AGENT
To: INTARCIA THERAPEUTICS, INC.
Reel/Frame 051739/0453 →
Release of Security Interest
Apr 17, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: INTARCIA THERAPEUTICS, INC.; INTARCIA IRELAND LIMITED
Reel/Frame 052433/0001 →